Counterfeit drugs and a new FDA warning on Avastin (bevacizumab) for cancer

man in wheelchair  Unfortunately, unscrupulous people are entering into high cost counterfeits of reputable manufacturer's medicines. Avastin (made by Genentech) was the subject of an FDA news release yesterday because the FDA identified a counterfeit version of the 400 mg/16 ml bottles. (see the full release at ww.fda.gov).

The FDA sent letters to 19 medical practices about counterfeit product and what it looks like. Apparently, the counterfeits have batch numbers that start with B6010, B6011 or B 86017 and are labeled with Roche as the manufacturer, instead of Genentech. Stupid crininals, the FDA-approved version of Avastin is marketed by Genentech. The truly unfortunate thing is that some patients suffering from cancer or macular degeneration may have received an injection from a vial with no active drug in it. Great work by the FDA and shame on the conterfeiters.

The experience with Avastin is NOT the first example of counterfeit drugs. Learn more about Conterfeit drugs at http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/CounterfeitMedicine/default.htm

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.